Pfizer (PFE) News Today $25.65 -0.13 (-0.50%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$25.66 +0.01 (+0.02%) As of 07/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Pfizer Down Today?Toggle Visibility of Why Is Pfizer Down Today?Pfizer Inc. (NYSE:PFE) shares are reacting to a mix of clinical pipeline news, dividend and earnings updates, analyst ratings and legal developments. Here’s what’s moving the stock: Positive Sentiment: Zacks highlights PFE’s strong earnings surprise history and expects another beat in its next report. Will Pfizer (PFE) Beat Estimates Again? Positive Sentiment: Pfizer and Astellas report positive Phase 3 EMBARK trial results for XTANDI plus leuprolide in non-metastatic hormone-sensitive prostate cancer, showing improved overall survival. Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study Positive Sentiment: New study data suggest abrocitinib could be a game-changer for atopic dermatitis patients. Pfizer’s New Study on Abrocitinib: A Potential Game-Changer for Atopic Dermatitis Positive Sentiment: An S&P 500 dividend roundup highlights PFE’s 6.7% indicated yield, with another small increase likely by year-end. “Nobody Ever Went Broke Taking a Profit” – Grab The Highest-Yielding S&P 500 Stocks Right Now Positive Sentiment: Shares climbed 1.7% on optimism around valuation and the strength of Pfizer’s pipeline. Pfizer (NYSE:PFE) Trading Up 1.7% – Should You Buy? Neutral Sentiment: Cantor Fitzgerald trims its FY2025 EPS forecast slightly to $3.09 but keeps a Neutral rating and $24 price target. Pfizer FY2025 EPS Forecast Decreased by Cantor Fitzgerald Neutral Sentiment: Bernstein reaffirms a Hold rating on PFE, citing steady cash flows and a deep drug pipeline. Bernstein Sticks to Its Hold Rating for Pfizer (PFE) Negative Sentiment: The stock dipped 1.3% amid profit-taking and sell-side caution over valuation. Pfizer (NYSE:PFE) Stock Price Down 1.3% – Here's Why Negative Sentiment: Pfizer and BioNTech appeal a UK patent ruling favoring Moderna, extending legal uncertainty around COVID-19 vaccine royalties. Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win Posted 18h agoAI Generated. May Contain Errors. PFE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Arizona State Retirement System Raises Stock Holdings in Pfizer Inc. (NYSE:PFE)5 hours ago | marketbeat.comFort Sheridan Advisors LLC Grows Stock Holdings in Pfizer Inc. (NYSE:PFE)July 12 at 7:54 AM | marketbeat.comPfizer Inc. (NYSE:PFE) Shares Sold by Cerity Partners LLCJuly 12 at 5:37 AM | marketbeat.comAllworth Financial LP Grows Holdings in Pfizer Inc. (NYSE:PFE)July 12 at 5:17 AM | marketbeat.comContrasting Bayer Aktiengesellschaft (OTCMKTS:BAYRY) & Pfizer (NYSE:PFE)July 12 at 3:11 AM | americanbankingnews.comFY2025 EPS Estimates for Pfizer Lowered by Cantor FitzgeraldJuly 12 at 2:15 AM | americanbankingnews.com“Nobody Ever Went Broke Taking a Profit” – Grab The Highest-Yielding S&P 500 Stocks Right NowJuly 11 at 1:29 PM | 247wallst.comPfizer (NYSE:PFE) Stock Price Down 1.3% - Here's WhyJuly 11 at 1:22 PM | marketbeat.comPfizer’s New Study on Abrocitinib: A Potential Game-Changer for Atopic DermatitisJuly 11 at 1:00 PM | theglobeandmail.comPfizer’s New Study on Abrocitinib: A Potential Game-Changer for Pediatric EczemaJuly 11 at 12:57 PM | tipranks.comPfizer’s Gene Therapy Study for Duchenne Muscular Dystrophy: A Potential Game-ChangerJuly 11 at 12:57 PM | tipranks.comPfizer’s Promising Migraine Study in Adolescents: What Investors Should KnowJuly 11 at 12:57 PM | tipranks.comPfizer’s Latest Study on HER2-positive Breast Cancer Treatment: Key Insights for InvestorsJuly 11 at 12:57 PM | tipranks.comPfizer’s Inclacumab Study: A Potential Game-Changer for Sickle Cell DiseaseJuly 11 at 12:57 PM | tipranks.comPfizer’s New Study on COVID-19 Vaccine Effectiveness: What Investors Need to KnowJuly 11 at 12:57 PM | tipranks.comPfizer’s New Phase 1 Study: A Potential Game-Changer in Cancer Treatment?July 11 at 12:57 PM | tipranks.comPfizer’s Study on Rimegepant and Pregnancy: What Investors Need to KnowJuly 11 at 12:57 PM | tipranks.comPfizer’s ABRYSVO Vaccine Study: A Potential Game-Changer for Infant RSV ProtectionJuly 11 at 12:57 PM | tipranks.comPfizer’s EPIC-Peds Study: New Insights into Pediatric COVID-19 TreatmentJuly 11 at 12:08 PM | tipranks.comPfizer’s Palbociclib Study: Real-World Insights on Advanced Breast Cancer TreatmentJuly 11 at 12:07 PM | tipranks.comPfizer’s Tukysa Study: A Closer Look at Safety and Efficacy in South KoreaJuly 11 at 12:07 PM | tipranks.comPfizer Inc. (NYSE:PFE) Stock Position Lifted by Callahan Advisors LLCJuly 11 at 8:40 AM | marketbeat.comBarry Investment Advisors LLC Decreases Position in Pfizer Inc. (NYSE:PFE)July 11 at 8:24 AM | marketbeat.comSteelPeak Wealth LLC Has $5.60 Million Stock Holdings in Pfizer Inc. (NYSE:PFE)July 11 at 8:23 AM | marketbeat.comCroban Purchases New Position in Pfizer Inc. (NYSE:PFE)July 11 at 7:30 AM | marketbeat.comBernstein Sticks to Its Hold Rating for Pfizer (PFE)July 10 at 10:50 PM | theglobeandmail.comPfizer, Astellas Report Xtandi Survival Win In Prostate Cancer StudyJuly 10 at 3:11 PM | benzinga.comPfizer (NYSE:PFE) Trading Up 1.7% - Should You Buy?July 10 at 1:13 PM | marketbeat.comPfizer’s New COVID-19 Treatment Study: A Potential Game Changer?July 10 at 12:48 PM | tipranks.comPfizer’s Promising Migraine Study: A Potential Game-Changer for Young PatientsJuly 10 at 12:48 PM | tipranks.comPfizer’s Abrocitinib Pregnancy Study: Safety Insights and Market ImpactJuly 10 at 12:48 PM | tipranks.comPfizer’s Abrysvo Study: Ensuring Safety for SeniorsJuly 10 at 12:48 PM | tipranks.comPfizer’s Rimegepant Study: A Potential Game-Changer for Pediatric Migraine TreatmentJuly 10 at 12:48 PM | tipranks.comPfizer’s New Study on PF-07985045: A Potential Game-Changer in Cancer Treatment?July 10 at 12:48 PM | tipranks.comPfizer’s Pediatric Migraine Study: A Potential Game-Changer for RimegepantJuly 10 at 12:48 PM | tipranks.comPfizer’s Real-World Study on Abrocitinib for Atopic Dermatitis: Market ImplicationsJuly 10 at 12:48 PM | tipranks.comPfizer’s Mevrometostat Study: A Potential Game-Changer in Cancer TreatmentJuly 10 at 12:48 PM | tipranks.comPfizer’s Cibinqo Study: A Closer Look at Its Market PotentialJuly 10 at 12:48 PM | tipranks.comCode Waechter LLC Buys Shares of 13,226 Pfizer Inc. (NYSE:PFE)July 10 at 9:30 AM | marketbeat.comPfizer (PFE) and BioNTech Appeal Patent Ruling Favoring ModernaJuly 10 at 9:05 AM | gurufocus.comPfizer FY2025 EPS Forecast Decreased by Cantor FitzgeraldJuly 10 at 8:41 AM | marketbeat.comPfizer (NYSE:PFE) HeadlineJuly 10 at 8:21 AM | gurufocus.comPfizer (PFE) Announces Positive Results from Prostate Cancer Drug Study | PFE Stock NewsJuly 10 at 8:21 AM | gurufocus.comPfizer, Astellas say Xtandi regimen hit secondary goal in late-stage trial for prostate cancerJuly 10 at 8:21 AM | seekingalpha.comPfizer, BioNTech challenge Moderna’s COVID vaccine patent win in U.K.July 10 at 8:21 AM | seekingalpha.comPfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent winJuly 10 at 7:18 AM | reuters.comPfizer Inc. (NYSE:PFE) Shares Sold by Lbp Am SaJuly 10 at 7:07 AM | marketbeat.comAxxcess Wealth Management LLC Sells 31,881 Shares of Pfizer Inc. (NYSE:PFE)July 10 at 7:06 AM | marketbeat.comXTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical RecurrenceJuly 10 at 6:45 AM | businesswire.comEU official Ursula von der Leyen comfortably survives a confidence voteEuropean Commission President Ursula von der Leyen has comfortably survived a vote of no confidence...July 10 at 6:12 AM | marketbeat.com Get Pfizer News Delivered to You Automatically Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter. Email Address PFE Media Mentions By Week PFE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PFE News Sentiment▼0.761.00▲Average Medical News Sentiment PFE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PFE Articles This Week▼11066▲PFE Articles Average Week Get Pfizer News Delivered to You Automatically Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Moderna News Novavax News Viatris News AbbVie News Bristol Myers Squibb News Johnson & Johnson News Eli Lilly and Company News Merck & Co., Inc. News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:PFE) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pfizer Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pfizer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PFE Stock Alerts